FDA warns websites illegally selling ADHD drug Adderall

[April 13, 2022]  (Reuters) - The U.S. Food and drug Administration and the U.S. Drug Enforcement Administration have jointly issued warning letters to two websites for illegally selling Adderall, a treatment for attention deficit hyperactivity disorder (ADHD).

Adderall is an FDA-approved prescription drug made of two stimulants amphetamine and dextroamphetamine, and has a high potential for abuse and addiction.

The health agency said the websites selling Adderall without a prescription pose a risk to consumers as the products, while being marketed as authentic, may be counterfeit, contaminated, expired or otherwise harmful.

"Illegal sale of prescription drug stimulants online puts Americans at risk...these particular types of online pharmacies also undermine our efforts to help consumers safely purchase legitimate prescription medicines over the internet," FDA Commissioner Robert M. Califf said.

Signage is seen outside of the Food and Drug Administration (FDA) headquarters in White Oak, Maryland, U.S., August 29, 2020. REUTERS/Andrew Kelly

The warning letters were issued on March 30 to Kubapharm.com and Premiumlightssupplier.com

The companies have 15 business days to respond to the agencies and inform them of the steps being taken to address any violations and prevent their recurrence.

Both the online operators did not immediately respond to Reuters' requests for comment.

(Reporting by Mrinalika Roy in Bengaluru; Editing by Krishna Chandra Eluri)
 

[© 2022 Thomson Reuters. All rights reserved.]  This material may not be published, broadcast, rewritten or redistributed.  Thompson Reuters is solely responsible for this content.